+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Rapid Diagnostics - Market Analysis, Trends, and Forecasts

  • ID: 4805394
  • Report
  • July 2019
  • Region: Global
  • 159 pages
  • Global Industry Analysts, Inc
1 of 2

FEATURED COMPANIES

  • Abbott Laboratories
  • Biomérieux Sa
  • Danaher Corporation
  • F. Hoffmann-La Roche Ag
  • Siemens Healthineers
  • MORE
Rapid Diagnostics market worldwide is projected to grow by US$20 Billion, guided by a compounded growth of 9.1%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Blood Glucose Testing, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$26.4 Billion by the year 2025, Blood Glucose Testing will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 7.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$783.6 Million to the region's size and clout in the next 5 to 6 years. Over US$1.5 Billion worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Blood Glucose Testing will reach a market size of US$1.5 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.1% over the next couple of years and add approximately US$5.5 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abbott Laboratories (USA); Becton, Dickinson and Company (USA); bioMérieux SA (France); Danaher Corporation (USA); F. Hoffmann-La Roche AG (Switzerland); Siemens Healthineers (Germany)
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ag
  • Siemens Healthineers
  • Biomérieux Sa
Note: Product cover images may vary from those shown
Adroll
adroll